Suppr超能文献

体外受精期间辅助生长激素治疗:一项随机、安慰剂对照研究。

Adjuvant growth hormone treatment during in vitro fertilization: a randomized, placebo-controlled study.

作者信息

Bergh C, Hillensjö T, Wikland M, Nilsson L, Borg G, Hamberger L

机构信息

Department of Obstetrics and Gynecology, University of Göteborg, Sahlgrenska Hospital, Sweden.

出版信息

Fertil Steril. 1994 Jul;62(1):113-20.

PMID:7516295
Abstract

OBJECTIVES

To explore the effect of recombinant, human GH on follicular development and oocyte retrieval after gonadotropin stimulation with the addition of GH or placebo to a standard IVF treatment regimen. Further, to investigate whether GH is a more effective adjuvant if the standard treatment regimen is preceded by GH injections.

DESIGN

A randomized, double-blind, parallel, placebo-controlled study.

SETTING

The IVF unit at university hospital.

PATIENTS

Forty normally ovulating women, age 25 to 38 years, with infertility because of tubal factors and being classified as "poor responders" with at least two previously performed and failed IVF attempts.

INTERVENTIONS

Human, recombinant GH (Genotropin, Kabi Pharmacia, Uppsala, Sweden) or placebo (0.1 IU/kg body weight per day) was given SC as pretreatment during down regulation with GnRH and during stimulation with hMG according to the randomized protocol.

MAIN OUTCOME MEASURES

Number of oocytes retrieved after stimulation, total amount of gonadotropin used, time required for stimulation, number of follicles developing, rate of fertilization, and cleavage in vitro. Further, the quality of embryos, development of the endometrium, rate of clinical pregnancy, and serum and follicular fluid (FF) concentrations of insulin-like growth factor I (IGF-I), insulin-like growth factor binding protein-1 (IGFBP-1), and IGFBP-3 were estimated.

RESULTS

The number of oocytes retrieved did not differ significantly between the groups, nor did the amount of hMG required for stimulation. The fertilization rate increased in patients who had received GH. Growth hormone caused a significant increase in serum and FF levels of IGF-I. An increase in serum IGFBP-3 could also be recorded in patients who had received GH.

CONCLUSION

Although certain beneficial effects were noted in GH-treated patients, the overall results did not support GH as a clinically useful adjuvant treatment.

摘要

目的

探讨重组人生长激素(GH)对在标准体外受精(IVF)治疗方案中添加GH或安慰剂进行促性腺激素刺激后卵泡发育及卵母细胞获取的影响。此外,研究在标准治疗方案之前先注射GH时,GH是否为更有效的辅助药物。

设计

一项随机、双盲、平行、安慰剂对照研究。

地点

大学医院的IVF科室。

患者

40名正常排卵的女性,年龄25至38岁,因输卵管因素不孕,且至少有过两次既往IVF尝试失败,被归类为“反应不良者”。

干预措施

根据随机方案,在使用促性腺激素释放激素(GnRH)进行降调节期间以及使用人绝经期促性腺激素(hMG)进行刺激期间,皮下注射重组人生长激素(Genotropin,瑞典乌普萨拉卡比制药公司生产)或安慰剂(每天0.1 IU/kg体重)作为预处理。

主要观察指标

刺激后获取的卵母细胞数量、使用的促性腺激素总量、刺激所需时间、发育的卵泡数量、受精率和体外分裂率。此外,评估胚胎质量、子宫内膜发育情况、临床妊娠率以及胰岛素样生长因子I(IGF-I)、胰岛素样生长因子结合蛋白-1(IGFBP-1)和IGFBP-3的血清及卵泡液(FF)浓度。

结果

两组之间获取的卵母细胞数量无显著差异,刺激所需的hMG量也无显著差异。接受GH治疗的患者受精率有所提高。生长激素使血清和FF中的IGF-I水平显著升高。接受GH治疗的患者血清IGFBP-3水平也有所升高。

结论

尽管在接受GH治疗的患者中观察到了某些有益效果,但总体结果并不支持将GH作为临床上有用的辅助治疗方法。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验